Isoliquiritigenin inhibits NLRP3 inflammasome activation with CAPS mutations by suppressing caspase‐1 activation and mutated NLRP3 aggregation

Documenti analoghi

• Isoliquiritigenin attenuates neuroinflammation after subarachnoid hemorrhage through inhibition of NF‐κB‐mediated NLRP3 inflammasome activation
  di: Zhang Wenfei, et al.
  Pubblicazione: (2024)
• Targeting the NLRP3 inflammasome in psoriasis
  di: Xiuhui Chen, et al.
  Pubblicazione: (2024)
• NLRP3 inflammasome activity and periodontal disease pathogenesis–A bidirectional relationship
  di: Andreea C. Didilescu, et al.
  Pubblicazione: (2024)
• Time‐of‐day control of mitochondria regulates NLRP3 inflammasome activation in macrophages
  di: James R. O'Siorain, et al.
  Pubblicazione: (2024)
• Regulation of the NLRP3 inflammasome by autophagy and mitophagy
  di: Suman Gupta, et al.
  Pubblicazione: (2024)